AssetMark Inc
TMDX icon

AssetMark Inc’s Transmedics TMDX Stock Holding History

AssetMark Inc’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$731 Sell
11
-8
-42% -$677 ﹤0.01% 3214
2026
Q1 		$1.89K Hold
19
– – ﹤0.01% 2874
2025
Q4 		$2.31K Buy
19
+6
+46% +$753 ﹤0.01% 2739
2025
Q3 		$1.46K Buy
13
+9
+225% +$1.05K ﹤0.01% 2699
2025
Q2 		$536 Hold
4
– – ﹤0.01% 2731
2025
Q1 		$269 Sell
4
-6
-60% -$413 ﹤0.01% 2500
2024
Q4 		$624 Hold
10
– – ﹤0.01% 2335
2024
Q3 		$1.57K Hold
10
– – ﹤0.01% 1922
2024
Q2 		$1.51K Buy
+10
New +$1.2K ﹤0.01% 1792

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

AssetMark Inc's TMDX Position: Q2 2026 in Review

AssetMark Inc reduced its Transmedics (TMDX) stake by 42% in Q2 2026, selling an estimated $677 and leaving 11 shares worth $731. The position accounts for ﹤0.01% of the portfolio, ranked #3214.

AssetMark Inc first reported a position in TMDX in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.31K in Q4 2025. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • AssetMark Inc held 11 shares of Transmedics worth $731 as of Q2 2026.
  • AssetMark Inc sold 8 Transmedics shares in Q2 2026, an estimated $677.
  • Transmedics made up ﹤0.01% of AssetMark Inc's portfolio in Q2 2026, its #3214 holding.
  • AssetMark Inc first reported a position in Transmedics in Q2 2024 and has held it in 9 quarters since.
  • AssetMark Inc's Transmedics position peaked at $2.31K in Q4 2025.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on AssetMark Inc's 13F filing for Q2 2026, filed 30 Jul 2026.